stocksbrew
Market
Explore
Watchlist
Market
Explore
Watchlist
stocksbrew.

Analyse any US stock, then track the ones you care about.

Appearance

Product

  • Market today
  • Explore
  • Watchlist
  • Earnings
  • US stocks
  • AI agent access

Free tools

  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Use cases
  • Developer API

Company

  • About
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

stocksbrew — Verified on SubmitForBacklinksFeatured on ScrollLaunchLaunched on FazierStocksBrew - Featured on Startup FameFeatured on Wired Business
CI
CI stock logo

The Cigna Group

Large Cap · Healthcare · Healthcare Plans

$278.50+$3.17 (+1.15%)
CI
CI stock logo

The Cigna Group

Large Cap · Healthcare · Healthcare Plans

$278.50+$3.17 (+1.15%)

Stock analysis

$278.50+$3.17 (+1.15%)

Get the AI take on CI

Track it to unlock the price chart, verdict and what could change it.

  • ✓Live price chart
  • ✓A clear accumulate, trim or avoid call

Free to track. No card required.

Stock Fundamentals & Key Indicators

52-week range
Low$239.51
High$315.47
Today $278.50
RSI (14)
37.5Neutral
03070100

Overall score

70/100

See the full financial picture

Open the five-year record, valuation checks and Wall Street view behind these scores.

  • ✓5 years of revenue, profit and cash flow
  • ✓Valuation and balance-sheet checks
  • ✓Business and geographic mix
  • ✓Analyst targets and recommendation trend

Free for 3 days, then $9/mo. Cancel anytime.

Analyst Rating and Sentiment

Analyst price targets

Current price

$278.5

Lowest

$290

Median target

$343

Highest

$400

LowHigh

Operating Record

Revenue

What's working

  • Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
  • Price / sales: You're paying a modest amount for each dollar of revenue coming in.

What to watch

  • Debt exceeds cash by $24.6B, increasing balance-sheet pressure, a warning sign.
  • Current ratio: Near-term bills are outrunning what's on hand to pay them.

What the market charges

Forward P/E

Favorable · 53% below avg

8.91x

Price / sales

Strong · Priced modestly against the revenue it brings in

0.26x

Price / FCF

Strong · Priced well within what its cash flow supports

8.19x

EV / EBITDA

Strong · Operating earnings comfortably support this price

7.78x

How efficiently it compounds

ROIC

Reasonable · A middling return on the capital it puts to work

13.4%

ROE

Middle ground · Mixed

16.8%

Debt / equity

Favorable · 0.73 - solid leverage

0.74x

Current ratio

Weak · Not enough on hand to cover near-term bills

0.85x

Peer Comparison

CompanyMkt capP/ERev growthScore
CI
CI stock logo
CIThe Cigna Group
$74.66B11.7+7.8%70
GM
GMED stock logo
GMEDGlobus Medical
$11.53B22.0+19.7%78
IN
INDV stock logo
INDVIndivior
$4.60B13.9+13.5%77
DX
DXCM stock logo
DXCMDexcom
$33.87B35.4+15.5%77
LL
LLY stock logo
LLYEli Lilly and Company
$1.11T40.1+49.6%76